Single dose of Oxford or Pfizer ‘80% effective at preventing hospital admission’

Carla Harmon
March 3, 2021

French regulators previously recommended that the Anglo-Swedish firm's jab be given to people aged 50 to 64 with pre-existing medical conditions.

It comes after similar findings were published by Scottish health authorities last week, which they hailed as "spectacular".

Mr Hancock told a Downing Street press conference the study was "extremely good news".

He said the data "gives us those first glimpses of how, if we are patient, and we give this vaccine programme time to have its full effect, it is going to hopefully take us into a very different world in the next few months".

More than 300,000 people were vaccinated in the last week, nearly one-fifth of the total doses injected since the first immunizations began December 14.

By contrast only 273,253 first doses of the AstraZeneca vaccine have been administered, and only 158,016 of the Moderna vaccine.

A further 104 people died within 28 days of testing positive for Covid-19 as of Monday - the lowest daily figure since October 26 - while there were another 5,455 lab-confirmed cases in the UK.

Protection against even developing symptomatic Covid-19 in the first place ranged between 57 and 61% for one dose of Pfizer and between 60 and 73% for the Oxford/AstraZeneca vaccine, the study found.

Meanwhile, people who had been vaccinated with one dose of the Oxford vaccine had an additional 37% lower risk of emergency hospital admission, while there is now insufficient follow-up data to assess the impact on death.

People aged over 65 to 74 could become eligible for the AstraZeneca vaccine in France, as results from a new study indicate that the AstraZeneca and Pfizer vaccines are equally effective.

Some European nations have refused to give it to the over 65s because data from the trials was mainly on its effect among younger adults.

A spokesperson for Health Minister Christine Elliott told CTV News Toronto the details of the vaccine roll out strategy are still being finalized, and the province is awaiting further guidance on the best use of the AstraZeneca vaccine.

"This adds to growing evidence showing that the vaccines are working to reduce infections and save lives", Mary Ramsay, PHE Head of Immunisation, said in the statement.

"I think it's really important that if a vaccine is available one takes it and that we don't concentrate too much on small differences in effectiveness between vaccines", Kelvin said.

Dr Susan Hopkins, of PHE, said they were tracking "very closely" the new Brazilian P1 coronavirus variant following the discovery of six cases in the UK.

Efficacy of the AstraZeneca vaccine is believed to be around 62 per cent.

Health officials have been able to contact all but one of these people. The whereabouts of the remaining individual is unknown as they did not complete their test registration card.

It has prompted an appeal for anyone without a result from a test on 12 or 13 February to come forward immediately by calling 119.

The rate of decline in deaths among the older age groups is also faster than in the under 80s, the health secretary said.

Earlier, Prime Minister Boris Johnson said the United Kingdom has "one of the toughest border regimes anywhere in the world for stopping people coming in to this country who may have variants of concern".

Other reports by iNewsToday